Agronomics Limited is a principal investment firm specializing in investments in funds, equity and equity related products. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, nascent industry of modern foods, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. Agronomics Limited was founded on May 3, 2011 and is based in Ramsey, Isle of Man.

Operations

ccc

Portfolio companies

ccc

Team[1]

ccc

Board of directors

Non-executive chairman

Richard Reed was the co-Founder of Innocent Drinks, Europe’s largest and most environmentally sustainable juice company, successfully exited to Coca Cola in 2013 for $600m. Now co-founder of Jam Jar Investments, a consumer goods VC, with early-stage investments in category defining companies such as Deliveroo, Blue Bottle Coffee, Graze.com and Tails.com.

Executive chairman

Jim Mellon, based in the Isle of Man, is an author, entrepreneur and an investor with interests in a number of sectors. He has substantial real estate holdings in Germany and the Isle of Man, as well as holdings in private and public companies through his private investment company Burnbrae Group.

After leaving Oxford, where he studied Philosophy, Politics and Economics, he worked in Asia and the United States in two fund management companies, GT Management and Thornton Management (Asia) Limited, before founding Regent Pacific Group Limited in 1991, subsequently quoted on the Hong Kong Stock Exchange.

Mr. Mellon is the co-author of five books, all written with a view to identifying emerging thematic trends leading to investment opportunities. Notably, in his book Wake Up!, he forecast the global financial crisis of ’08-’09. His latest book played a small role in bringing ageing research into the mainstream, and lead to the formation of the company which is co-founder and Chairman, Juvenescence which is a leader in the field. Mr Mellon is a non-executive director of Condor Gold plc, the executive chairman of the board of Manx Financial Group plc, and the non-executive chairman of the board of SalvaRx Group Plc, all of which are listed on the Alternative Investment Market of the London Stock Exchange. He is also co-founder and Chairman of Regent Pacific Group Limited, (which is listed in Hong Kong), and a non-executive director of Portage Biotech Inc (which is dually listed on the Over the Counter Bulletin Board of NASDAQ of the United States and the Canadian Securities Exchange.

Non-executive director

Marisa Drew is the inaugural Chief Sustainability Officer (CSO) of Standard Chartered Bank Plc.  She assumed this role in July 2022 and is responsible for setting the bank’s sustainability strategy and the delivery of the firm’s commitment to net zero carbon emissions by 2050 as well as overseeing the sustainable finance client-facing activities of the bank.  At Standard Chartered, Ms Drew is a member of the Corporate, Commercial  Investment Banking (CCIB) Management Team and the Global Reputational Risk Committee.  She also serves as Chair of the Sustainability Forum and Co-Chair of the CCIB Diversity and Inclusion Council.

She previously held the CSO role for Credit Suisse and also held the role of CEO of the Sustainability Strategy, Advisory & Finance Group (SSAF) since 2020. Ms Drew Co-Chaired the Sustainability Leaders Committee and served on the ESG Steering Committee, the Climate Risk Strategy Steering Committee and the UK Reputational Risk Committee of the bank.

Before this, Ms Drew ran several businesses for Credit Suisse over her 19 years at the bank, including EMEA Investment Banking and Capital Markets.  Ms Drew also worked for Merrill Lynch for eleven years and relocated to London in 1999 where she was instrumental in the formation of their European Leveraged Finance Group. Prior to joining Merrill Lynch, Ms Drew worked for a private equity firm and the investment bank, Kidder Peabody.

Ms Drew serves as a Non-executive Director (NED) of Liberty Global Plc, the publicly listed telecoms and broadband operator, and was a NED for the Swiss publicly-listed telecoms company, Sunrise AG.

She further serves on the advisory boards of numerous leadership, sustainability, humanitarian, environmental and civil society organisations. She sits on the Advisory Board of the City of London Corporation, the Aspen Institute UK and the Milken Institute Center for Strategic  Philanthropy. She is also a member of the  FCA’s Markets Practitioner Panel and served on several High Level Working Groups (HLGs) sponsored  by the World Economic Forum and the UN, including as co-chair of the HLG for  Humanitarian Aid and the Oceans Panel. Ms Drew’s external activities also include the EMEA Advisory Board for the UK charity, Room-to-Read.

Ms Drew received a BA in Finance and Marketing with distinction from the University of Virginia’s McIntire School of Commerce in 1986 and an MBA with distinction from the University of Pennsylvania’s Wharton School in 1992.

Non-executive director

David Giampaolo is the founder and Chief Executive of Pi Capital. David previously founded, built up and sold several businesses and health club chains in the US and Europe. He has financial interests in several other businesses and industries and has been involved as an investor, advisor and board member of some of the largest and most successful health & fitness companies in the world including Fitness First, 24 Hour Fitness, Zumba Fitness and SARVA (India’s largest chain of yoga, mindfulness and beyond).

He is on the board of Coalition for Inclusive Capitalism, Chairman of Gousto and is a senior advisor to AMG (Affiliated Managers Group, Inc.) and BC Partners. David is a member of YPO and CEO global business organisations and a trustee of Speakers4Schools.org and Pro BonoEconomics.

Finance director

Denham Eke is the Managing Director of Burnbrae Group Limited, a private international asset management company. He began his career in stockbroking with Sheppards & Chase before moving into corporate planning for Hogg Robinson plc, a major multinational insurance broker. He is a director of many years’ standing of both public and private companies involved in the financial services, property, mining, and manufacturing sectors.

He is Chairman of Webis Holdings PLC, Co-Chairman of Billing Services Group Limited, and Chief Executive Officer of Manx Financial Group PLC – all quoted on the London AIM market.

Operations Team

Co-founder

Anthony Chow began his career working for ANZ Banking Group in Sydney Australia, where he worked as an analyst for four years in the corporate banking, leverage finance and private equity teams before moving to London in 2007 to work for Burnbrae Group. He has spent the past 15 years working directly with Jim Mellon, looking closely at investments within the field of biotech and pharma, inclusive of longevity. In 2018, he co-founded Agronomics alongside Jim Mellon. Anthony holds a Bachelor of Economics and Finance from The University of Sydney and a Post Graduate Diploma in Accounting from Macquarie University. He was awarded the CFA designation in 2010.

Anthony sits on the board or is a board observer to a number of cellular agriculture portfolio companies, including Formo, VitroLabs, California Cultured, Onego Bio, SuperMeat, All G Foods, HydGene and Meatable.

Principal

Laura Turner joined the team in July 2019. She holds a M.Chem Chemistry degree from the University of Oxford, and spent time during her fourth year masters project working in the Chemical Biology department at UC Berkeley, California, focused on the genetic modification of aldolase enzymes. This technology is identical to the precision fermentation tools utilised by companies within the field of cellular agriculture to produce valuable animal proteins via the genetic engineering of microbes. Laura conducts sector research, assists in due diligence of prospective companies and monitors deal flow amongst many other things.

Senior Associate

Hamood Al Fanna has a MBS in Finance from Massey University, BSc in Biotechnology from Sultan Qaboos University. Conducted research on production of cellulase from thermophilic bacteria. Over 5 years experience in venture capital, main focus in Biotechnology and Healthcare.

Head of investor relations

Melissa Moon joined Agronomics in January 2023 as Head of Investor Relations and Corporate Communications.

Previously Melissa held the post of Head of Marketing and Corporate Communications for Berkeley Energia, a Spanish uranium mining company, listed on LSE/ASX/BME which raised over $100 million of capital.

As an experienced Investor Relations Consultant in the Natural Resources sector, Melissa oversaw marketing strategy and corporate communications for numerous London and Australian listed companies – including the AIM IPO of Trident Royalties and the ASX IPO of GreenTech Metals.

Melissa holds an LLB Law (Hons) and the Certificate in Investor Relations from The IR Society.

Market

Total addressable market (TAM)

ccc

Serviceable addressable market (SAM)

ccc

Serviceable obtainable market (SOM)

ccc

Financials

ccc

Risks

ccc

Valuation

ccc

Appendix

ccc

Beta risk profile

Beta value Risk rating
0 to 0.50 Low
0.50 to 1.50 Medium
1.50 to 3.00 High
3.00 and above Extremely high

Pantheon Resources beta calculation

Pantheon Resources beta calculation
Date iShares MSCI World ETF unit price (USD) Pantheon Resources plc share price (GBP) iShares MSCI World ETF unit price change (%) Pantheon Resources plc share price change (%)
01/10/2018 85.25 16.24
01/11/2018 86.21 17.1 1% 5%
01/12/2018 78.87 16 -9% -6%
01/01/2019 84.96 23.375 8% 46%
01/02/2019 87.49 24.75 3% 6%
01/03/2019 88.79 28.6 1% 16%
01/04/2019 92.09 21.425 4% -25%
01/05/2019 86.76 21.25 -6% -1%
01/06/2019 91.02 21.25 5% 0%
01/07/2019 91.86 18.68 1% -12%
01/08/2019 89.84 17.9 -2% -4%
01/09/2019 91.78 16.03 2% -10%
01/10/2019 94.12 16.25 3% 1%
01/11/2019 96.76 16.5 3% 2%
01/12/2019 98.78 16.5 2% 0%
01/01/2020 97.73 16.5 -1% 0%
01/02/2020 89.67 11.95 -8% -28%
01/03/2020 77.93 13 -13% 9%
01/04/2020 86.36 13.75 11% 6%
01/05/2020 90.7 15.95 5% 16%
01/06/2020 92.14 13.775 2% -14%
01/07/2020 96.65 21.15 5% 54%
01/08/2020 102.96 22.35 7% 6%
01/09/2020 99.52 37.2 -3% 66%
01/10/2020 96.53 31 -3% -17%
01/11/2020 108.94 37.4 13% 21%
01/12/2020 112.41 43.5 3% 16%
01/01/2021 111.49 36.3 -1% -17%
01/02/2021 114.27 39.1 2% 8%
01/03/2021 118.49 35.7 4% -9%
01/04/2021 123.61 34.25 4% -4%
01/05/2021 125.6 29.4 2% -14%
01/06/2021 126.57 41.25 1% 40%
01/07/2021 128.83 55.3 2% 34%
01/08/2021 132.02 59.7 2% 8%
01/09/2021 126.46 71.6 -4% 20%
01/10/2021 133.84 77.6 6% 8%
01/11/2021 131.1 69.6 -2% -10%
01/12/2021 135.32 77.3 3% 11%
01/01/2022 128.32 79.6 -5% 3%
01/02/2022 124.58 142 -3% 78%
01/03/2022 128.16 117.6 3% -17%
01/04/2022 117.42 123.2 -8% 5%
01/05/2022 117.94 100.6 0% -18%
01/06/2022 106.88 89.4 -9% -11%
01/07/2022 115.57 117 8% 31%
01/08/2022 110.28 133.7 -5% 14%
01/09/2022 99.95 104.1 -9% -22%
01/10/2022 107.42 100.1 7% -4%
01/11/2022 115.44 72.95 7% -27%
01/12/2022 109.25 42.52 -5% -42%
01/01/2023 117.01 50.15 7% 18%
01/02/2023 113.98 57.1 -3% 14%
01/03/2023 117.67 23.64 3% -59%
01/04/2023 119.79 18.67 2% -21%
01/05/2023 118.6 15.74 -1% -16%
01/06/2023 124.52 12.71 5% -19%
01/07/2023 128.54 10.8 3% -15%
01/08/2023 125.7 25 -2% 131%
01/09/2023 125.91 22.42 0% -10%
Pantheon Resources beta and adjusted beta
Pantheon Resources
Beta 0.3262
Adjusted beta 0.5508